premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

As this $9 billion market cap pharma company will join the S&P MidCap 400, we reiterate ROIV as a TOP PICK.  Cash reserves are growing and the company trades at 1.5x book.  We recommend trailing up the stop (from $7.50) to $9.50, looking to achieve $15 -- upside potential of 33%.  Yield 0%    

(Analysts’ price target is $15.90)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

GPOR is actively producing natural gas from the highly prolific Utica and Marcellus basins.  Despite lower commodity values, the company is still building cash reserves, allowing it to retire debt and buy back shares.  The company is wisely deferring some capital projects at the moment, but still expects to hit productivity targets this year.  We recommend setting a stop loss at $125, looking to achieve $195 -- upside potential of 29%.  Yield 0%

(Analysts’ price target is $195.33)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

PARR is responsible for over 180,000 bpd of refined product refining, supplying Hawaii with approximately 80,000 bpd, Montana with over 50,000 bpd, and Wyoming with over 15,000 bpd.  As the summer driving season approaches, refining margins will grow.  It trades at 7x earnings, 1.3x book value, and supports a 44% ROE.  We recommend setting a stop-loss at $21, looking to achieve $41.50 -- upside potential of 45%.  Yield 0%  

(Analysts’ price target is $41.50)
COMMENT
Halo on AI stocks has been dented?

Certainly in April it was, for good reason. Exuberance is a stage of market cycles that we've all experienced. With AI, we saw exuberance. Companies reported and didn't blow numbers out of the water, or project higher and higher results. So the market said hang on a minute, maybe we priced things in a little too high and too soon.

It doesn't mean that these aren't great companies with great prospects. It's all about pricing. The market spends very little time in fair value. Mostly the pendulum swings from overbought to oversold, and that's what makes a market.

COMMENT
Below index weighting in tech mega-caps?

Yes. If you look at the Magnificent 7, which control 30% of the market value of the S&P 500, he's about half weight. So he has about a 15% exposure. Long-term wonderful companies, including GOOG, AAPL and AMZN. But there comes a point where you let risk become too big a part of your investment thesis. Over-concentration is a big definition of risk.

He wants to participate in these major themes, but he's pulled back a bit. Loves these quality companies from the bottom-up. Thinks he can supplement the missing 15% with other companies that are, perhaps, a little bit neglected, better value, more stable. Those can give his clients just as good a return, but with less risk.

DON'T BUY

None of these chip companies should be considered a long-term hold. Very cyclical sector. Be careful about entry point, with a planned exit. Expensive at 37x. Core to AI revolution. Great space, but be selective. He owns QCOM.

HOLD

None of the chip companies should be considered a long-term hold. Very cyclical sector. Great space, but be selective. This name has diversification to offset some of that risk, with good exposure to AI.

COMMENT
Trigger capital gains to avoid changes to inclusion rates?

You should absolutely get advice from both the investment and accounting sides. Highly complex, specific to each individual. Corporations don't get the inclusion rate advantage, so if there's something in your portfolio you're not sure about and it's on the chopping block, sell before June 25.

Other than that, you might want to get ahead of the game by selling off a little bit. But remember, you're pre-paying the government. And with those dollars, over perhaps 4-5 years, you could recoup the loss that you'd have going from a 55% inclusion rate to 66%.

Be aware of it and plan, but he's hesitant to say you should be on the trigger to pre-pay on capital gains. Plus, a different government could potentially move the rate right back to where it was. Important to at least have the discussion.

For a general understanding of capital gains, see the blog from 2022 at goodreid.com.

WATCH
HD vs. LOW

Owned HD 25 years ago. Took profits 10-12 years ago, and switched to LOW. Based on LOW successfully adopting the HD playbook to grow gross margins, and on valuation (LOW was 4 multiple points lower than HD). HD is now trading at a low 20s multiple, and LOW is about 17x. 

Out of both right now. He became skittish on consumer. It's not they've been poor performers, but the new choices have rewarded clients to a better extent.

Great companies, great franchises. Always looking for an entry point, it's not yet. HD reported this morning, shy on revenue, mentioned consumer pulling back. He wouldn't be surprised to be in one or the other in the not-too-distant future.

WATCH
HD vs. LOW

Owned HD 25 years ago. Took profits 10-12 years ago, and switched to LOW. Based on LOW successfully adopting the HD playbook to grow gross margins, and on valuation (LOW was 4 multiple points lower than HD). HD is now trading at a low 20s multiple, and LOW is about 17x. 

Out of both right now. He became skittish on consumer. It's not they've been poor performers, but the new choices have rewarded clients to a better extent.

Great companies, great franchises. Always looking for an entry point, it's not yet. HD reported this morning, shy on revenue, mentioned consumer pulling back. He wouldn't be surprised to be in one or the other in the not-too-distant future.

DON'T BUY

Great company, but expensive. Lots of promise, but high valuation anticipates great success. He thinks they'll be successful, but you have to be sure you're not paying for that in the stock already. He owns AMGN.

HOLD

Owns this instead of NVO. A much less troublesome valuation. Also has a weight-loss drug in trial. You want to be in before the good news, not after.

SELL

Reported dreadful results the other week, he sold. Painful, but enough was enough. Promise of vertical integration making it a juggernaut just didn't happen. 

Have to get used to being wrong as an investor some of the time. It's what you do when you're wrong that's a big factor in your results.

WEAK BUY

Hard to argue with its results. He owns a lot of the companies that Berkshire does, such as AAPL, CVX, BAC. Quality companies trading at reasonable prices, that pass the test of profitability and growth, with excitement around the business.

He doesn't want to pay the premium to have BRK manage companies for him. May make sense for an individual investor.

HOLD

Copper trade has legs. Wind at its back from cyclical factors and from a secular standpoint. All the fiscal stimulus in the US is about infrastructure, and a lot of copper is needed. EVs, too, use more copper. Tons of power generation needed for AI, and copper is a key component.

Well positioned, levered to copper prices. For every 10 cent increase in price of copper, it makes $400M in cashflow.